Early intervention when weight gain starts
XTALKS WEBINAR: Sarcopenia: Changes and Challenges in Body Composition with GLP-1 Receptor Agonist-based Weight Loss Therapies Live and On-Demand: Friday, September 6, 2024 , at 10am EDT (4pm CEST / EU-Central) Register for this free webinar to learn about the latest clinical trial data on GLP-1 receptor agonist-based therapies and their impact on weight loss and body composition
In search of new drugs, AstraZeneca, Sanofi strike deals with AI firms AstraZeneca has decided to tap into the power of artificial intelligence (AI) to develop an antibody for cancer by entering into a deal with AI biologics firm Absci Corporation
Interactions between the GLP-1 pathway and addictive drugs, such as nicotine, opioids, and psychostimulants, have been demonstrated in rodents (Figure 3), and these are reviewed in the following sections
These medications are not approved for use during pregnancy, and their safety profile in early gestation remains unclear